JPS61140525A - 抗ストレス剤 - Google Patents
抗ストレス剤Info
- Publication number
- JPS61140525A JPS61140525A JP59263545A JP26354584A JPS61140525A JP S61140525 A JPS61140525 A JP S61140525A JP 59263545 A JP59263545 A JP 59263545A JP 26354584 A JP26354584 A JP 26354584A JP S61140525 A JPS61140525 A JP S61140525A
- Authority
- JP
- Japan
- Prior art keywords
- fraction
- dialysis
- stress
- garlic
- subjected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002180 anti-stress Effects 0.000 title claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000004611 garlic Nutrition 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 11
- 238000000502 dialysis Methods 0.000 claims abstract description 11
- 238000002523 gelfiltration Methods 0.000 claims abstract description 8
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 8
- 238000005571 anion exchange chromatography Methods 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 2
- 244000245420 ail Species 0.000 claims 1
- 240000002234 Allium sativum Species 0.000 abstract description 11
- 239000006000 Garlic extract Substances 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 235000020706 garlic extract Nutrition 0.000 abstract description 9
- 239000000243 solution Substances 0.000 abstract description 4
- 239000007924 injection Substances 0.000 abstract description 3
- 238000002347 injection Methods 0.000 abstract description 3
- 239000000843 powder Substances 0.000 abstract description 3
- 239000002775 capsule Substances 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 150000002484 inorganic compounds Chemical class 0.000 abstract 1
- 229910010272 inorganic material Inorganic materials 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- 239000012528 membrane Substances 0.000 description 13
- 238000000605 extraction Methods 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 5
- 210000000628 antibody-producing cell Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000003918 fraction a Anatomy 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920000298 Cellophane Polymers 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 235000020374 simple syrup Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N Arginine Chemical compound OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 241000557833 Hua gabonii Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- -1 Na C1 Chemical class 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 206010042209 Stress Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920003053 polystyrene-divinylbenzene Polymers 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59263545A JPS61140525A (ja) | 1984-12-13 | 1984-12-13 | 抗ストレス剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59263545A JPS61140525A (ja) | 1984-12-13 | 1984-12-13 | 抗ストレス剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61140525A true JPS61140525A (ja) | 1986-06-27 |
| JPH0469609B2 JPH0469609B2 (enrdf_load_stackoverflow) | 1992-11-06 |
Family
ID=17391024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59263545A Granted JPS61140525A (ja) | 1984-12-13 | 1984-12-13 | 抗ストレス剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61140525A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002049454A1 (en) * | 2000-12-21 | 2002-06-27 | Ogawa & Co., Ltd. | PROCESS FOR PRODUCING allumiumEXTRACTS |
| JP2002186449A (ja) * | 2000-12-21 | 2002-07-02 | Ogawa & Co Ltd | アリウム属植物エキスの製造方法 |
-
1984
- 1984-12-13 JP JP59263545A patent/JPS61140525A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002049454A1 (en) * | 2000-12-21 | 2002-06-27 | Ogawa & Co., Ltd. | PROCESS FOR PRODUCING allumiumEXTRACTS |
| JP2002186449A (ja) * | 2000-12-21 | 2002-07-02 | Ogawa & Co Ltd | アリウム属植物エキスの製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0469609B2 (enrdf_load_stackoverflow) | 1992-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102030834B (zh) | 从茶花中提取制备茶花多糖的方法及所得茶花多糖的用途 | |
| CN101480437B (zh) | 一种麻杏石甘汤制剂的制备方法 | |
| JPH045652B2 (enrdf_load_stackoverflow) | ||
| JP2002538214A (ja) | 心血管疾病治療用薬剤組成物及びその製造方法 | |
| CN114601865A (zh) | 桑提取物在制备治疗溃疡性结肠炎的药物中的应用 | |
| CN106963777A (zh) | 一种“黄芩苷‑小檗碱”复合物的制备方法及其应用 | |
| CN103830374B (zh) | 三叶糖脂清在高尿酸血症中的应用 | |
| CN110664860B (zh) | 一种增强免疫力的组合物及其制备方法 | |
| JPS61140525A (ja) | 抗ストレス剤 | |
| CN101190906B (zh) | 红花黄色素b的制备方法及其应用 | |
| CN115645473A (zh) | 竹叶兰及其提取物在制备治疗肾损伤药物中的应用 | |
| WO2008091064A1 (en) | Composition comprising trachelospermi caulis and pyrola japonica extracts for the treatment and prevention of inflammatory diseases | |
| CN108452073B (zh) | 一种复合植物凝集素及其制备方法和用途 | |
| CN101502536B (zh) | 香柏总黄酮及其制备方法与医药用途 | |
| CN106565849B (zh) | 一种景天三七多糖的制备方法及其应用 | |
| CN115414398B (zh) | 板栗提取物及其制备方法以及其在降血糖产品中的应用 | |
| CN101647858B (zh) | 一种丹参水溶性提取物的制备方法 | |
| CN100560569C (zh) | 一种莲子心生物碱提取物、其制备方法及其在制备心脑血管疾病药物中的应用 | |
| JPS60197627A (ja) | クミスクチン健康茶 | |
| CN115462530B (zh) | 板栗仁提取物及其提取方法和在抗氧化产品中的应用 | |
| CN113398186B (zh) | 一种紫花地丁提取物及其制备方法和应用 | |
| JPH0469611B2 (enrdf_load_stackoverflow) | ||
| CN108553540A (zh) | 一种治疗抑郁症的片剂的制备工艺 | |
| CN108635445A (zh) | 岩陀黄酮、黄柏黄酮和当归多糖复合物在制备兽药中的应用 | |
| CN110898170B (zh) | 一种治疗代谢综合征的中药组合物及其制剂 |